HbA1c ReductionCalorie restriction

Clinical evidence dossier

Calorie restriction

HbA1c

Evidence signal

Authoritative evidence signal

strong

This is an authoritative evidence signal supplied by Clinical Reference. It is not a formal clinical grade, treatment recommendation, or pooled effect estimate.

Evidence snapshot

Authoritative support records
4
Supporting studies available for review
4
Randomized trials
4
Reported effects
10

Clinical conclusion

Calorie restriction shows a strong positive evidence signal for improving HbA1c across the studied comparisons.

Observed effects

Observed study estimates; not a pooled treatment effect.

Change from baseline

Absolute change

-1.5 to -1.5 %

2 eligible estimates52–52 weeksObserved median: -1.5 %

Between-group effect

Absolute change

-0.5 to -0.2 %

2 eligible estimates12–12 weeksObserved median: -0.35 %

Change from baseline

Mean difference

-1.36 to 0 %

3 eligible estimates12–12 weeksObserved median: -1.3 %

Evidence composition

Non-randomized studies
0
Other designs
0
Unresolved designs
0
Magnitude-eligible effects
7

Consistency

Authoritative consistency classification

consistent

Positive
3
No effect
1
Mixed
0
Negative
0

Population and applicability

Structured population data were available for 4 of 4 supporting studies. 4 studies described participants with type 2 diabetes. 4 studies described adult participants.

This population information refers to the materialized supporting studies available for review. Omitted support records remain part of the authoritative support accounting and are available through the audit experience.

View reported population descriptions

These descriptions are reported across the supporting studies; they are not a single synthesized population.

  • Adults diagnosed with type 2 diabetes.
  • Individuals seeking dietary interventions for diabetes management.
  • Individuals looking for effective dietary strategies for weight loss.
  • Adults newly diagnosed with type 2 diabetes.
  • Individuals seeking dietary interventions for obesity management.
  • Adults aged 18-65 with Type 2 Diabetes.
  • Individuals seeking weight loss strategies.

Limitations

  • Evidence uses heterogeneous comparison contexts: active_comparator, usual_care.

Supporting evidence

Inspect the authoritative studies and omitted support records for this dossier.

View supporting evidence